Search - tctmd.com

Displaying 341 - 360 of 802

Sort: Relevancy | Date

News Industry News

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

September 15, 2014

News Conference News TCT 2014

PCI for CTO Ups Survival vs. Medical Therapy, CABG

September 14, 2014

News Conference News TCT 2014

Lively Debate on Use of TAVR for Lower-Risk Patients

September 14, 2014

News Industry News

ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

September 14, 2014

News Industry News

Significant Patient Benefits With Edwards SAPIEN Valve Demonstrated In 5-Year PARTNER Trial Data

September 13, 2014

News Conference News TCT 2014

PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients

Yael L. Maxwell

September 13, 2014

News Industry News

New Study Compares Cost-Effectiveness of Transcatheter Aortic Valve Replacement with Surgical Valve Replacement in High Risk Patients

September 13, 2014

News Conference News TCT 2014

Michael J. Mack, MD, Becomes First Surgeon to Receive TCT Career Achievement Award

September 13, 2014

News Industry News

Medtronic CoreValve System Sustains Positive Outcomes Through Two Years in Extreme Risk Patients

September 13, 2014

News Industry News

Medtronic CoreValve Data Demonstrate Favorable Cost Effectiveness Compared to Open-Heart Surgery in High Risk Patients

September 13, 2014

News Industry News

Clinical Trial Examines the Long Term Outcomes of a Self-Expanding Transcatheter Aortic Valve in Inoperable Patients with Aortic Stenosis

September 13, 2014

News Industry News

5 Year Data from Clinical Trial Studying TAVR in Patients with Severe Aortic Stenosis Demonstrates Persistent Mortality Benefit and Lower Rate of Repeat Hospitalizations Compared to Standard Therapy

September 13, 2014

News Industry News

Symetis receives CE Mark approval for transfemoral transcatheter aortic heart valve system ACURATE neo™, and launches product with first commercial implantations

September 12, 2014

News Industry News

Medtronic Announces First U.S. Implants in Clinical Study of Recapturable CoreValve Evolut R

September 10, 2014

News Daily News

Study Explores Predictors of Nonhealing in CLI Patients After Endovascular Therapy

Caitlin E. Cox

September 02, 2014

News Industry News

Sorin Group Announces First World Implant of CROWN PRT™ Heart Valve

September 02, 2014

News Daily News

MitraClip Repair Safe, Effective for MR in Large European Registry

September 02, 2014

News Conference News ESC 2014

GARY: Transapical TAVR Appears Inherently Riskier Than Transvascular

Caitlin E. Cox

September 02, 2014

News Daily News

Assessing Aortic Valve Calcification May Help Predict Paravalvular Leak After TAVR

Yael L. Maxwell

September 02, 2014

News Daily News

研究表明，早在PCI后3个月即可安全实施非心脏手术

Yael L. Maxwell

August 20, 2014

Advertisement

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

PCI for CTO Ups Survival vs. Medical Therapy, CABG

Lively Debate on Use of TAVR for Lower-Risk Patients

ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

Significant Patient Benefits With Edwards SAPIEN Valve Demonstrated In 5-Year PARTNER Trial Data

PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients

New Study Compares Cost-Effectiveness of Transcatheter Aortic Valve Replacement with Surgical Valve Replacement in High Risk Patients

Michael J. Mack, MD, Becomes First Surgeon to Receive TCT Career Achievement Award

Medtronic CoreValve System Sustains Positive Outcomes Through Two Years in Extreme Risk Patients

Medtronic CoreValve Data Demonstrate Favorable Cost Effectiveness Compared to Open-Heart Surgery in High Risk Patients

Clinical Trial Examines the Long Term Outcomes of a Self-Expanding Transcatheter Aortic Valve in Inoperable Patients with Aortic Stenosis

5 Year Data from Clinical Trial Studying TAVR in Patients with Severe Aortic Stenosis Demonstrates Persistent Mortality Benefit and Lower Rate of Repeat Hospitalizations Compared to Standard Therapy

Symetis receives CE Mark approval for transfemoral transcatheter aortic heart valve system ACURATE neo™, and launches product with first commercial implantations

Medtronic Announces First U.S. Implants in Clinical Study of Recapturable CoreValve Evolut R

Study Explores Predictors of Nonhealing in CLI Patients After Endovascular Therapy

Sorin Group Announces First World Implant of CROWN PRT™ Heart Valve

MitraClip Repair Safe, Effective for MR in Large European Registry

GARY: Transapical TAVR Appears Inherently Riskier Than Transvascular

Assessing Aortic Valve Calcification May Help Predict Paravalvular Leak After TAVR

研究表明，早在PCI后3个月即可安全实施非心脏手术

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content